Europe's regulator to inspect Ranbaxy's India plant in June

MUMBAI Thu Apr 10, 2014 12:48am IST

Related Topics

Stocks

   

MUMBAI (Reuters) - Europe's drug regulator said on Wednesday an inspection of Indian generic drugmaker Ranbaxy Laboratories Ltd's(RANB.NS) Dewas plant in India is planned for June, amid concerns about its production processes after a spate of regulatory sanctions.

Ranbaxy, which owner Japan's Daiichi Sankyo Ltd (4568.T) agreed to sell it to Sun Pharmaceutical Industries Ltd (SUN.NS) for $3.2 billion on Monday, suspended production at the Dewas plant in February to examine processes.

The company's voluntary suspension at Dewas and another plant in Toansa in the northern Punjab state in February, came after a spate of sanctions against it by the U.S. Food and Drug Administration (FDA) due to poor manufacturing processes.

Ranbaxy informed authorities in the European Union that its internal investigation revealed the Dewas site failed some so-called good manufacturing practices, the European Medicines Agency (EMA) said in a statement issued to Reuters.

A Ranbaxy spokesman did not immediately respond to requests for comment on the EMA statement.

Imports from Dewas had already been banned by the FDA back in 2008 after the agency found violations of drug manufacturing standards there. The FDA has also banned shipments from the three other Ranbaxy plants in India.

(Reporting by Zeba Siddiqui; Editing by Sumeet Chatterjee and Elaine Hardcastle)

FILED UNDER:
Photo

After wave of QE, onus shifts to leaders to boost economy

DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.

Earnings Season

Reuters Showcase

Obama In India

Obama In India

In parting shot, Obama prods India on religious freedom.  Full Article 

Market Rally

Market Rally

Sensex, Nifty hit record high for fifth straight session.  Full Article 

Restructuring

Restructuring

Max India to be split into three separate companies.  Full Article 

India’s Male Tenor

India’s Male Tenor

India’s lone male tenor wants to ‘Indianise’ opera  Full Article 

Indian Equities

Indian Equities

Hornbill raising $250 mln to invest in equities - partner.  Full Article 

Ratings Downgrade

Ratings Downgrade

S&P downgrades Russia's sovereign credit rating to "junk".  Full Article 

Facebook Outage

Facebook Outage

Facebook takes blame for service outages, which hit wider Web.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage